MAB is a technology research association developing next-generation production technologies for modern- and next-generation biopharmaceuticals. Bringing together our expertise, we aim to establish an industrial technology platform for biopharmaceuticals.
- In detail, we aim towards
- ⅰ) improvement of the upstream process technology for protein production,
- ⅱ) improvement of the downstream process technology for protein separation and purification,
- ⅲ) improvement of the quality assessment technology,
- ⅳ) expansion and improvement of virus-security control technology,
- ⅴ) combining four technologies to promote the optimization of the manufacturing process, and
- ⅵ) we aim to integrate the developed technologies and attempt to use them in practice.